{"schema_version":"secwatch.filing_event.v1","accession":"0000950170-23-000394","form_type":"8-K","ticker":"RXST","cik":"0001111485","company_name":"RxSight, Inc.","filed_at":"2023-01-09T23:59:59+00:00","discovered_at":"2026-05-14T18:03:43.899563+00:00","generated_at":"2026-06-20T17:29:54.602646+00:00","sec_items":["2.02","8.01","9.01"],"event_type":"earnings","sentiment":"positive","materiality_score":0.7,"calibrated_materiality_score":0.7,"confidence":"high","headline":"RxSight reports preliminary Q4 2022 revenue $16.1M, up 91% YoY; full-year $49.0M, up 117%","bullets":["Q4 2022 revenue $16.1M (+91% YoY); 57 LDDs sold, installed base 400 LDDs as of Dec 31, 2022.","Full-year 2022 revenue $49.0M (+117% YoY); 25,284 LALs sold.","Preliminary cash, equivalents & short-term investments $105.8M, including $6.0M ATM net proceeds.","Management expects continued growth in 2023; audited results targeted for early March 2023."],"urls":{"canonical":"https://secwatch.observer/filing/0000950170-23-000394","json":"https://secwatch.observer/filing/0000950170-23-000394.json","markdown":"https://secwatch.observer/filing/0000950170-23-000394.md","text":"https://secwatch.observer/filing/0000950170-23-000394.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1111485/000095017023000394/0000950170-23-000394-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1111485/000095017023000394/rxst-20230108.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-20T17:29:54.602646+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"797def616b3ad276780123380e1bfe0a9d5e5546","claim":"RxSight, Inc. reported fourth quarter and full-year 2022 results: revenue approximately $16.1 million.","evidence_excerpt":"operational results for the fourth quarter and full-year 2022. Preliminary Unaudited Results • Preliminary unaudited fourth quarter 2022 revenue is expected to be approximately $16.1 million, representing growth of approximately 91% compared to the prior year period, driven by: o The sale of 57 Light Delivery Devices (LDDTMs), expanding the installed base to 400 LDDs","evidence_source":"SEC 8-K Item 2.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1111485/000095017023000394/0000950170-23-000394-index.htm","confidence":0.95,"family_label":"Earnings Releases","details":[{"label":"Period","value":"fourth quarter and full-year 2022"},{"label":"Revenue","value":"approximately $16.1 million"},{"label":"Result","value":"preliminary results"}],"fact_type":"earnings_release"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}